CellDrop is commercializing a first of its kind encapsulated, allogenic stem cell therapy for faster and more durable healing of tendon and ligament injuries in elite equine athletes.
Implementation in the veterinary market will provide crucial evidence and early revenue generation to speed its translation to humans, where it can treat numerous debilitating orthopedic conditions like Osteoarthritis.